Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise

Patent metadata

Field	Value
Publication number	US-10791928-B2
Application number	US-202016796830-A
Country	US
Kind code	B2
Filing date	Feb 20, 2020
Priority date	May 18, 2007
Publication date	Oct 6, 2020
Grant date	Oct 6, 2020

Abstract

Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.

First claim

What is claimed is:

1. A transcutaneous electrochemical glucose sensor configured for implantation in a host, the transcutaneous electrochemical glucose sensor comprising:
a first portion configured to remain outside a body of the host during sensor use, wherein the first portion is configured to operably connect with sensor electronics; and
a second portion configured to be inserted inside the body of the host during sensor use, wherein the second portion comprises:
a working electrode configured for use in measuring a signal indicative of a glucose concentration of the host, wherein the working electrode comprises a first sensing area, a second sensing area, a third sensing area, and a fourth sensing area;
wherein each of the sensing areas comprises a surface that is shaped like a circle, a dot, or an oval;
wherein the sensing areas are spaced along a length of the second portion of the transcutaneous electrochemical glucose sensor;
wherein the second portion of the transcutaneous electrochemical glucose sensor comprises a distal end;
wherein the first sensing area is located closer to the distal end of the second portion of the transcutaneous electrochemical glucose sensor than the second sensing area, the third sensing area, and the fourth sensing area; wherein the second sensing area is located closer to the distal end of the second portion of the transcutaneous electrochemical glucose sensor than the third sensing area and the fourth sensing area; wherein the third sensing area is located closer to the distal end of the second portion of the transcutaneous electrochemical glucose sensor than the fourth sensing area;

a membrane covering at least a portion of the working electrode; and
a reference electrode disposed at least in part on the second portion of the transcutaneous electrochemical glucose sensor;

wherein the first sensing area, the second sensing area, the third sensing area, and the fourth sensing area are disposed along a common axis of insertion of the second portion of the transcutaneous electrochemical glucose sensor into the host;
wherein the first sensing area, the second sensing area, the third sensing area, and the fourth sensing area are located closer to the distal end of the second portion of the electrochemical transcutaneous sensor than the reference electrode; and
wherein the transcutaneous electrochemical glucose sensor has a planar shape.

2. The transcutaneous electrochemical glucose sensor of claim 1 , wherein the membrane comprises a layer configured to control a diffusion of glucose therethrough.

3. The transcutaneous electrochemical glucose sensor of claim 2 , wherein the layer comprises polyurethane.

4. The transcutaneous electrochemical glucose sensor of claim 1 , wherein the reference electrode comprises silver and silver chloride.

5. The transcutaneous electrochemical glucose sensor of claim 1 , further comprising a counter electrode disposed at least in part on the second portion of the transcutaneous electrochemical glucose sensor.

6. The transcutaneous electrochemical glucose sensor of claim 1 , wherein sensing areas are arranged such that a distance from the first sensing area to the second sensing area is substantially equal to a distance from the second sensing area to the third sensing area.

7. The transcutaneous electrochemical glucose sensor of claim 1 , wherein the membrane is a membrane system.

8. The transcutaneous electrochemical glucose sensor of claim 1 , wherein the membrane is a membrane layer.

9. The transcutaneous electrochemical glucose sensor of claim 1 , wherein each of the sensing areas comprises an enzyme.

Assignees

• Dexcom Inc

Inventors

• Simpson Peter C
• Boock Robert J
• Brister Mark C
• Rixman Monica A
• Woo Kum Ming
• Nguyen Lisa
• Brunner Seth R
• Chee Arthur
• Nicholas Melissa A
• Wightlin Matthew D
• Pryor Jack
• Markovic Dubravka

Classifications

• A61B5/14532 Primary

  for measuring glucose, e.g. by tissue impedance measurement · CPC title

• A61B5/14865

  invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors · CPC title

• A61B5/14735

  comprising an immobilised reagent · CPC title

• A61B5/6848

  Needles · CPC title

• A61B5/1486

  using enzyme electrodes, e.g. with immobilised oxidase · CPC title